跳至主要内容
临床试验/NCT05094674
NCT05094674Unknown不适用

Clinical Validation of Biosafety Technologies Breath Analyser Tests for the Diagnosis of COVID-19; the Project Aims to Validate the Diagnostic Device and to Assess the Comparative Performance With RT-PCR Currently Being Deployed in the NHS.

Tera Group2 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2021年10月22日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
500
试验地点
2
主要终点
Rate of positive and negative cases in collected breath samples using breath analyser test.

研究概览

简要总结

The Sponsor has developed a rapid screening tool intended to determine if the subject tested is COVID-19-free (Negative to COVID-19).

详细描述

Within this proposed project, the NHS will collect two diagnostic or screening tests per participant. One sample will be used by NHS and be run through regular diagnostics. The second, will be breath sample which will be tested using the BioSafety Technologies Ltd, rapid screening tool. This will use a pre-defined protocol. These tests would then be compared to assess the diagnostic efficacy including sensitivity and specificities. We will be aiming to achieve a significant comparison to ensure certainty and to exploit the information for proposing a novel diagnostic system to enhance capabilities to scale up the testing of patients. The proposed activity involves clinical validation of BioSafety Testing, to enhance the performance of detection along with clinicians.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 18 years or above.
  • Requiring a diagnostic or screening RT-PCR test for COVID-19

排除标准

  • Subjects under general anaesthesia
  • The inability to personally sign the consent form.
  • The inability to exhale breath

结局指标

主要结局

Rate of positive and negative cases in collected breath samples using breath analyser test.

时间窗: The collection of an additional samples requiring COVID 19 diagnostic evaluation will take approximately 1 minute from initial collection of the sample

次要结局

未报告次要终点

研究者

发起方
Tera Group
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验